Iterum Therapeutics plc (ITRMF) Net Shares Issued and Repurchased (2017 - 2025)

Iterum Therapeutics has reported Net Shares Issued and Repurchased for 9 years, with the latest figure at $4583.0 in Q1 2025.

• On a quarterly basis, Net Shares Issued and Repurchased changed N/A year-over-year to $4583.0 in Q1 2025; TTM through Mar 2025 was $4583.0, a N/A change from a year earlier, with the FY2024 full-year figure at $179935.0, down 79.02% from the prior year.
• Net Shares Issued and Repurchased was $4583.0 for Q1 2025 at Iterum Therapeutics, down from $179935.0 in the prior quarter.
• The five-year high for Net Shares Issued and Repurchased was $1.0 million in Q4 2021, with the low at $4583.0 in Q1 2025.
• Average Net Shares Issued and Repurchased over 5 years is $448096.6, with a median of $230040.0 recorded in 2021.
• The sharpest annual moves came in 2021 and 2022: Net Shares Issued and Repurchased soared 11002.48% in 2021, then plunged 80.83% in 2022.
• Over 5 years, Net Shares Issued and Repurchased stood at $1.0 million in 2021, then slumped by 80.83% to $197085.0 in 2022, then jumped by 335.09% to $857500.0 in 2023, then sank by 79.02% to $179935.0 in 2024, then sank by 97.45% to $4583.0 in 2025.
• The last three Net Shares Issued and Repurchased figures came in at $4583.0 (Q1 2025), $179935.0 (Q4 2024), and $857500.0 (Q4 2023), per Business Quant data.